US Patent 11622933 Soluble estradiol capsule for vaginal insertion
Patent 11622933 was granted and assigned to TherapeuticsMD on April, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Brian A. Bernick0
Frederick D. Sancilio0
Janice Louise Cacace0
Julia M. Amadio0
Neda Irani0
Peter H. R. Persicaner0
Thorsteinn Thorsteinsson0
Edits on 30 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 29 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Apr, 2023
Golden AI
Infobox
Edits on 12 Apr, 2023
Golden AI
Edits made to:
Infobox (+37 properties)
Article (+278 characters)
US Patent 11622933 Soluble estradiol capsule for vaginal insertion
Article
According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116229330
Date of Patent
April 11, 2023
0Patent Application Number
167739030
Date Filed
January 27, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11622933 Soluble estradiol capsule for vaginal insertion
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.